jili k.o

jili k.o Aden Holloway explodes as No. 5 Alabama rolls over South Dakota State

HO CHI MINH CITY, Vietnam , Dec. 18, 2024 /PRNewswire/ — The HoSkar Night series has become a favorite event for hospitality and real estate professionals across Asia , connecting industry leaders, developers, and innovators in a vibrant networking atmosphere. In 2024, the series embarked on an incredible journey, covering major cities such as Ho Chi Minh City , Hanoi , Phnom Penh , Bangkok , and Manila cementing its status as a key platform for meaningful dialogue and collaboration in the industry. Launched in 2024, the HoSkar Talk – Developers Seminar marked a new milestone, bringing industry professionals together to discuss critical topics shaping the future of the hospitality and real estate industries. Looking ahead to 2025, the HoSkar Talk will dive deep into themes such as Wellness in Real Estate, Branded Residences, Technological Advancements in Hospitality, F&B Trends, and Design in Project Development. Mark your calendars for the 2025 event series, scheduled in key cities across the region: Bangkok (8th May), Phnom Penh (29th May), Manila (19th June), Ho Chi Minh City (10th July), Hanoi (29th October), Dubai (6th November) and Ho Chi Minh City (27th November). Kick off 2025 with us by joining the first HoSkar Night of the year in Ho Chi Minh City on 18th March, from 6 PM – 9 PM at Vinpearl Landmark 81, Autograph Collection. This event is part of the Meet The Experts conference, the largest Hospitality and Real Estate conference for industry professionals in the region, promising to set the tone for an exciting year ahead. Brought to you by WeHub, the largest community for hospitality and real estate developers, as well as senior industry professionals in the region. With its commitment to fostering innovation, collaboration, and growth, WeHub provides a robust platform for members to share knowledge, explore opportunities, and stay ahead in a competitive market. HoSkar Night would not be possible without the incredible support of our sponsors and partners. If you’d like to showcase your brand, share your expertise, or collaborate with us to make 2025 even more impactful, we’d love to hear from you. For sponsorship and collaboration inquiries, contact us at Host@wehubyou.com . Visit the HoSkar Night website at https://hoskarnight.com/ or find out more information at WeHub LinkedIn . Vision Asia Pacific is a registered company which owns WeHub and organizes many event series, including Meet The Experts conference (MTE) and HoSkar Night networking event. View original content to download multimedia: https://www.prnewswire.com/apac/news-releases/hoskar-night-event-series-2025-lets-explore-the-real-estate-market-together-302333251.html SOURCE VISION ASIA PACIFIC LIMITED LIABILITY COMPANYNovember sees high box office turnout as people are returning to cinemas

Mother orca and children make 'grocery shopping' trip near downtown VancouverAmazon investing another $10 billion in Ohio-based data centers

Discrimination based on source of income widespread despite Illinois law, housing advocates sayBrady Tkachuk remembers skipping school to watch his dad play in the 2006 Olympics. Now it’s his turn — finally — to play international hockey against the best players in the world. The Ottawa Senators captain has been named to the United States’s roster for the 4 Nations Face-Off tournament. He’s one of 20 players on Canadian NHL teams set to take part in February’s battle between Canada, the U.S., Finland and Sweden. “You grow up and it’s Stanley Cup and winning a gold medal. Those are the two goals,” Tkachuk said Thursday. “I think I’ve dreamt of an event like this since I was a little kid. I know it’s still a long way away, but can’t help just be super excited about it.” The rosters unveiled Wednesday include the NHL’s brightest lights, from Edmonton Oilers superstar Connor McDavid and Toronto Maple Leafs sniper Auston Matthews to Winnipeg Jets goalie Connor Hellebuyck and Vancouver Canucks blueliner Quinn Hughes. Many clubs are sending players to different international squads, including the Sens, who’ll see Tkachuk play for the U.S. while goalie Linus Ullmark takes the crease for Sweden. Ullmark was quick to answer when asked whether he planned to trash talk his NHL teammate. “Buddy, he’ll sucker punch me out of the blue if I do that,” he said with a grin. “No, no. I’m not going to do that. ... But there might be a wink here and there for certain players if I have the opportunity to play.” The 4 Nations tournament — set to take place in Montreal and Boston — is the closest NHLers have come to playing best-on-best international hockey since the 2016 World Cup. “I think it’s going to be really exciting for the players, of course, but the fans,” said Matthews. “It’s been a while since we’ve seen kind of best-on-best like this. It’s a pretty good precursor for the Olympics the following year. I think everybody’s really excited. It’ll be fun.” Now that the rosters have been announced, speculation has turned to details such as which players will skate together and what each country’s power play will look like. “We were joking around, like, if you’re a coach sitting in the dressing room, looking at the whiteboard, picking out lines and power plays and combinations and all that, there are so many great options,” said Jets defenceman Josh Morrissey, who’s on Team Canada. “To get that opportunity, it’s definitely something I don’t take lightly.” The tournament will replace the 2025 NHL all-star game, but Oilers defenceman Mattias Ekholm believes hockey fans will still get a chance to see the sport’s very best. “I think every team that’s in the tournament is pretty much an all-star roster,” said Ekholm, who’s been named to Sweden’s team. “You can look at all the rosters and think whatever you think. But, in my opinion, it’s going to come down to whoever can get it together the quickest and to the highest level in that short period of time. I mean, you lose the first game and you’re pretty much out of it, almost.” Ekholm will be joined on Sweden’s squad by regional rival Rasmus Andersson. The Calgary Flames defenceman will partake in international hockey for the first time since the U-18 World Championships in 2014. From playoffs to parenthood, a variety of factors have barred Andersson from playing in a tre kronor jersey over the past decade. “I’ve never been able to play (at the senior level) and I’ve always loved playing for my country. It’s something I never take for granted,” he said. “It’s the first time in — what — eight years that it’s best-on-best. ... I’m super excited about it.” Winger Patrik Laine just returned to the Canadiens’ lineup on Tuesday, but said he had a feeling he was in the running to make Finland’s team. “It’s always really cool to put on that jersey. It’s always a privilege to be representing our country,” he said. “And obviously with these best-on-best events, the World Cup for us didn’t go too well last time. So we’ll try to get a little redemption this time. I feel like we’ve got a really good team.” Finland tends to be underrated heading into international hockey play, said Canucks goalie Kevin Lankinen. “We’re just a small country from the north there. It’s pretty unique that we’ve produced so many good players,” he said. “And just being part of (4 Nations), I think we want to go there with the winning mindset and prove that we’re the top country in the world.” Being tapped for the tournament had some NHLers reminiscing about their favourite memories of watching their country play Thursday. Canucks centre Elias Pettersson can still vividly recall the gold-medal game where Sweden bested Finland at the 2006 Olympics in Turin. “I was so fired up watching (Henrik) Lundqvist, I was goalie the next practise,” he said. “It brings back good memories and now to be part of this, it’s very cool.” — With files from Donna Spencer in Calgary. This report by The Canadian Press was first published Dec. 5, 2024. Gemma Karstens-Smith, The Canadian Press

Acadian Timber Corp. to Issue Quarterly Dividend of $0.29 (TSE:ADN)Knee Osteoarthritis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone 11-25-2024 08:30 PM CET | Health & Medicine Press release from: DelveIinsight Business Research (Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working towards developing 60+ Knee Osteoarthritis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Knee Osteoarthritis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Knee Osteoarthritis Market. The Knee Osteoarthritis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details. Some of the key takeaways from the Knee Osteoarthritis Pipeline Report: https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr •Companies across the globe are diligently working toward developing novel Knee Osteoarthritis treatment therapies with a considerable amount of success over the years. •Knee Osteoarthritis companies working in the treatment market are Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others, are developing therapies for the Knee Osteoarthritis treatment •Emerging Knee Osteoarthritis therapies in the different phases of clinical trials are- M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, and others are expected to have a significant impact on the Knee Osteoarthritis market in the coming years. •In September 2024, Cytonics has announced the completion of subject enrollment for its Phase I clinical trial of CYT-108, a potential disease-modifying therapy for knee osteoarthritis (OA). CYT-108 is a recombinant variant of the alpha-2-macroglobulin blood serum protease inhibitor. The company initiated this Phase I trial in July, which is a first-in-human, multicenter, six-month, double-blind, randomized controlled trial (RCT) aimed at evaluating the safety and efficacy of CYT-108 in patients with unilateral, mild-to-moderate primary OA of the knee. •In June 2024, Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage company focused on macrophage reprogramming immunotherapy, announced a positive interim data update from a Phase I/II investigator-initiated clinical trial of AllocetraTM in patients with end-stage knee osteoarthritis who were candidates for knee replacement surgery. Knee Osteoarthritis Overview Knee osteoarthritis is a degenerative joint condition that affects the knees. It is the most common type of osteoarthritis, a chronic joint disorder characterized by the breakdown of cartilage, the protective tissue that cushions the ends of bones within the joint. Get a Free Sample PDF Report to know more about Knee Osteoarthritis Pipeline Therapeutic Assessment- https://www.delveinsight.com/report-store/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Emerging Knee Osteoarthritis Drugs Under Different Phases of Clinical Development Include: •M6495: Merck KGaA •PPV 06: Peptinov •LG00034053: LG Chem •StroMel: Akan Bioscience •TTAX03: BioTissue,Inc. •EP-104IAR: Eupraxia Pharmaceuticals Inc. •OLP 1002: OliPass Corporation •JTA-004: Bone Therapeutics •X 0002: Techfields Pharma •Lorecivivint: Biosplice Therapeutics Knee Osteoarthritis Route of Administration Knee Osteoarthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as •Oral •Parenteral •Intravenous •Subcutaneous •Topical Knee Osteoarthritis Molecule Type Knee Osteoarthritis Products have been categorized under various Molecule types, such as •Monoclonal Antibody •Peptides •Polymer •Small molecule •Gene therapy Knee Osteoarthritis Pipeline Therapeutics Assessment •Knee Osteoarthritis Assessment by Product Type •Knee Osteoarthritis By Stage and Product Type •Knee Osteoarthritis Assessment by Route of Administration •Knee Osteoarthritis By Stage and Route of Administration •Knee Osteoarthritis Assessment by Molecule Type •Knee Osteoarthritis by Stage and Molecule Type DelveInsight's Knee Osteoarthritis Report covers around 40+ products under different phases of clinical development like •Late-stage products (Phase III) •Mid-stage products (Phase II) •Early-stage product (Phase I) •Pre-clinical and Discovery stage candidates •Discontinued & Inactive candidates •Route of Administration Further Knee Osteoarthritis product details are provided in the report. Download the Knee Osteoarthritis pipeline report to learn more about the emerging Knee Osteoarthritis therapies at: https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the key companies in the Knee Osteoarthritis Therapeutics Market include: Key companies developing therapies for Knee Osteoarthritis are - Eli Lilly and Company, Nature Cell Co. Ltd., Novo Nordisk A/S, Flexion Therapeutics, Inc., Grünenthal GmbH, Tissue Tech Inc., Kolon TissueGene, Inc., Bioventus LLC, Akan Biosciences, LLC, Genascence Corporation, Immunis, Inc., Novartis, Biosplice Therapeutics, Sorrento Therapeutics, Inc., Novartis, Celltex Therapeutics Corporation, MiMedx Group, Inc., Rho, Inc., Techfields Pharma Co. Ltd, Saol Therapeutics Inc, Centrexion Therapeutics, Taiwan Liposome Company, MiMedx, Ampio Pharmaceuticals, ReNu, Medipost, and others. Knee Osteoarthritis Pipeline Analysis: The Knee Osteoarthritis pipeline report provides insights into •The report provides detailed insights about companies that are developing therapies for the treatment of Knee Osteoarthritis with aggregate therapies developed by each company for the same. •It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Knee Osteoarthritis Treatment. •Knee Osteoarthritis key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. •Knee Osteoarthritis Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. •Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Knee Osteoarthritis market. The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Download Sample PDF Report to know more about Knee Osteoarthritis drugs and therapies- https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Knee Osteoarthritis Pipeline Market Drivers •Increase in prevalence of Osteoarthritis, robust Knee Osteoarthritis Pipeline are some of the important factors that are fueling the Knee Osteoarthritis Market. Knee Osteoarthritis Pipeline Market Barriers •However, risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment, high cost associated with the treatment and other factors are creating obstacles in the Knee Osteoarthritis Market growth. Scope of Knee Osteoarthritis Pipeline Drug Insight •Coverage: Global •Key Knee Osteoarthritis Companies: Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharmaceuticals Inc., OliPass Corporation, Bone Therapeutics, Techfields Pharma, Biosplice Therapeutics, and others •Key Knee Osteoarthritis Therapies: M6495, PPV 06, LG00034053, StroMel, TTAX03, EP-104IAR, OLP 1002, JTA-004, X 0002, Lorecivivint, and others •Knee Osteoarthritis Therapeutic Assessment: Knee Osteoarthritis current marketed and Knee Osteoarthritis emerging therapies •Knee Osteoarthritis Market Dynamics: Knee Osteoarthritis market drivers and Knee Osteoarthritis market barriers Request for Sample PDF Report for Knee Osteoarthritis Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/knee-osteoarthritis-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Table of Contents 1. Knee Osteoarthritis Report Introduction 2. Knee Osteoarthritis Executive Summary 3. Knee Osteoarthritis Overview 4. Knee Osteoarthritis- Analytical Perspective In-depth Commercial Assessment 5. Knee Osteoarthritis Pipeline Therapeutics 6. Knee Osteoarthritis Late Stage Products (Phase II/III) 7. Knee Osteoarthritis Mid Stage Products (Phase II) 8. Knee Osteoarthritis Early Stage Products (Phase I) 9. Knee Osteoarthritis Preclinical Stage Products 10. Knee Osteoarthritis Therapeutics Assessment 11. Knee Osteoarthritis Inactive Products 12. Company-University Collaborations (Licensing/Partnering) Analysis 13. Knee Osteoarthritis Key Companies 14. Knee Osteoarthritis Key Products 15. Knee Osteoarthritis Unmet Needs 16 . Knee Osteoarthritis Market Drivers and Barriers 17. Knee Osteoarthritis Future Perspectives and Conclusion 18. Knee Osteoarthritis Analyst Views 19. Appendix 20. About DelveInsight Related Reports: Knee Osteoarthritis Market https://www.delveinsight.com/report-store/knee-osteoarthritis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr DelveInsight's 'Knee Osteoarthritis Market Insights, Epidemiology, and Market Forecast-2034' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom). Latest Reports Offered By DelveInsight: •Neuroendoscopy Market: https://www.delveinsight.com/report-store/neuroendoscopy-market •Nosocomial Infections Market: https://www.delveinsight.com/report-store/nosocomial-infections-market •Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market •Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market •Dry Eye Disease Market: https://www.delveinsight.com/report-store/dry-eye-disease-market-insights •Nonalcoholic Steatohepatitis Market: https://www.delveinsight.com/report-store/nonalcoholic-steatohepatitis-nash-market •Female Infertility Market: https://www.delveinsight.com/report-store/female-infertility-market •Gonorrhea Market: https://www.delveinsight.com/report-store/gonorrhea-market •Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market Contact Us: Gaurav Bora gbora@delveinsight.com +14699457679 Healthcare Consulting https://www.delveinsight.com/consulting-services About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach. This release was published on openPR.

Talent Management Software Market Future Innovations and Forecast 2024-2031 11-30-2024 06:05 PM CET | IT, New Media & Software Press release from: SkyQuest Technology The Talent Management Software Market is experiencing rapid growth, fueled by advancements in hardware, software, and digital infrastructure. With services spanning cloud computing, cybersecurity, data analytics, and artificial intelligence, the market is at the forefront of digital transformation across industries. Emerging technologies such as 5G, blockchain, and IoT are unlocking unprecedented opportunities, driving innovation and expansion. Get a Free Sample Report With Table Of Contents: https://www.skyquestt.com/sample-request/talent-management-software-market Market Size and Growth: Global Talent Management Software Market size was valued at USD 9.17 Billion in 2023 and is poised to grow from USD 10.32 Billion in 2024 to USD 23.70 Billion by 2031, growing at a CAGR of 12.6% in the forecast period (2024-2031). The most valuable investment indicators are insights into key market trends, making it easier for potential participants to make informed decisions. The research seeks to identify numerous growth opportunities that readers can consider and capitalize on by utilizing all the relevant information. By closely analyzing critical factors that influence growth, such as pricing, production, profit margins, and value chain dynamics, future market expansion can be predicted with greater precision. Key Market Players: ADP, LLC (US) Ultimate Software (US) IBM Corporation (US) Cornerstone OnDemand, Inc. (US) Kronos Incorporated (US) Ceridian HCM, Inc. (US) Infor (US) Talentsoft (France) PageUp People (Australia) Saba Software, Inc. (US) Region-wise Market Insights The regional analysis offers detailed breakdowns of revenue, sales, and market share for key geographies. This section includes future growth projections, pricing strategies, and other critical metrics. Regions covered in the report: North America: United States, Canada, Mexico Europe: Germany, France, UK, Russia, Italy Asia-Pacific: China, Japan, Korea, India, Southeast Asia South America: Brazil, Argentina, Colombia Middle East & Africa: Saudi Arabia, UAE, Egypt, Nigeria, South Africa For Personalized Insights, Speak with Our Experts: https://www.skyquestt.com/speak-with-analyst/talent-management-software-market Segments covered in the Talent Management Software Market include: Solution Recruiting and Applicant Tracking, Performance Management, Learning and Development, and Compensation Management Deployment On-Premise and Cloud-Based Organization size Small and Medium-sized Enterprises (SMEs), and Large Enterprises Talent Management Software Market Size and Scope The Talent Management Software market has shown significant growth in recent years, fueled by rising demand for power electronics across industries such as automotive, telecommunications, and renewable energy. This market is set to grow further as the global adoption of electric vehicles and renewable energy increases. Talent Management Software are highly valued for their superior thermal conductivity, electrical insulation, and mechanical strength, making them essential components in power modules and electronic devices. With ongoing technological and manufacturing advancements, the applications of Talent Management Software are expected to expand, encompassing a broader range of uses in the near future. For a Comprehensive Report on the Talent Management Software Market 2024, Visit: https://www.skyquestt.com/report/talent-management-software-market Frequently Asked Questions What are the key global trends influencing the market? Who are the top manufacturers, and what are their strategies? How is the market evolving across regions? What are the major challenges and opportunities in the Talent Management Software Market? About Us: SkyQuest is an IP-focused Research and Investment Bank and Technology Accelerator. We offer access to technologies, markets, and financing across sectors like Life Sciences, CleanTech, AgriTech, NanoTech, and Information & Communication Technology. We collaborate closely with innovators, entrepreneurs, companies, and investors to help them leverage external R&D sources and optimize the economic potential of their intellectual assets. Our expertise in innovation management and commercialization spans North America, Europe, ASEAN, and Asia Pacific. Contact: Mr. Jagraj Singh Skyquest Technology 1 Apache Way, Westford, Massachusetts 01886, USA (+1) 351-333-4748 Visit our website: Skyquest Technology This release was published on openPR.Arclin unveils striking new brand that stands out in the material science industry with exacting precision and a bold new lookCommerce Department to reduce Intel’s funding on semiconductors

The Bruins knocked off South Carolina on Sunday to rise to the top of the polls and are out to a 5-0 start.(BPT) - The holidays bring a whirlwind of excitement, sales, and unfortunately also scams. Black Friday, Small Business Saturday, and Cyber Week mean increased online transactions, e-commerce traffic, and a heightened focus on fulfilling customer orders — all of which make small businesses, especially micro-businesses, prime targets for cybercriminals. According to Bank of America's Small Business Owner's Report , more than half of small business owners said cybersecurity threats have impacted their business. Unlike larger corporations with dedicated IT departments, many small and micro businesses lack proper security infrastructure, leaving them more vulnerable to and harmed by threats. A single scam or breach can be costly and can put a business behind during the busy holiday season. Scammers know how to exploit the season's hustle and bustle. But don't let the Grinch steal your seasonal success — arm yourself with these tips from the pros at Norton Small Business to stay protected and keep the holiday cheer intact. The Naughty List: Common Holiday Cyber Scams In today's digital-first world, cybersecurity is no longer optional — it's a necessity. With cyber threats evolving constantly, safeguarding your business requires vigilance, informed employees, and robust practices. Investing in cybersecurity tools is a simple way to address these concerns. The Nice List: 7 Cyber Safety Tips for the Holidays In a world where scams are harder to detect it is good to have extra help. Owners and employees can check in real time if something might be a scam with the free Norton Genie app . With a simple screen shot, this AI-powered scam detection tool can tell you if a text message, social media post, email or website message is likely to be a scam, what makes the content suspicious, and what to do next. Beyond just protecting your systems, it's essential to build trust with your customers by showing them that your business takes cybersecurity seriously. Displaying security badges on your website, being transparent about how customer data is protected, and offering secure payment options can go a long way in fostering customer confidence and retention. The holidays are a time of opportunity for both small businesses and scammers. By adopting these best practices, you can protect your business, your customers, and your peace of mind this season. Think of Norton Small Business as your holiday helper, protecting your devices and data while you focus on operating your business. With easy setup and robust features, it's your always-on IT department working 24/7 to protect your business and employees. Visit https://us.norton.com/products/small-business for more information.

Previous: #337jili
Next: jili 63 free 120